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SUMMARY
The p21-activated kinases (PAKs) are important mediators of cytoskeletal reorganization,
cell motility and transcriptional events regulated by the Rho-family GTPases Rac and Cdc42.
PAK activation by serum components is strongly dependent on cell adhesion to the extracellular
matrix (ECM). PAK binds directly to the Nck adapter protein, an interaction thought to play an
important role in regulation and localization of PAK activity. This report demonstrates that the
interaction of PAK with Nck is dynamically regulated by cell adhesion. PAK-Nck binding is
rapidly lost after cell detachment and rapidly restored after re-adhesion to the ECM protein
fibronectin, suggesting a rapidly reversible mode of regulation. Furthermore, the loss of Nck
binding correlates with changes in the phosphorylation state of PAK in non-adherent cells, as
evidenced by electrophoretic mobility shift and phosphorylation within a sequence known to
mediate interaction with Nck. The ability of cell adhesion to regulate PAK phosphorylation and
interaction with Nck may contribute to the anchorage-dependence of PAK activation, as well as
the localization of activated PAK within a cell.
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INTRODUCTION
The p21-activated kinase (PAK) family comprises the best-characterized effectors for
the Rho-family GTPases1 Cdc42 and Rac (1). As such, PAK activity has been implicated in
Cdc42- and Rac-mediated regulation of gene expression and modulation of the actin cytoskeleton
and cell motility (2,3). PAK is also involved in the regulation of signaling cascades involving the
mitogen-activated protein kinase (MAPK) (4-6) and Jun N-terminal kinases (JNK) (5,7,8). PAK
activity is stimulated by a variety of soluble factors (e.g. insulin, thrombin, PDGF and EGF (1,2,9))
as well as by cellular adhesion to extracellular matrix (ECM) (10,11). Recently, it has been
reported that activation of PAK by soluble factors is highly dependent on cell adhesion (12,13),
and this may contribute to the anchorage-dependence of MAPK activation (13,14). One of these
reports offers strong evidence that the lack of PAK activation in non-adherent cells is due to an
uncoupling of PAK from activated Rac at the plasma membrane (12). Specifically, the deficiency
in PAK activation in non-adherent cells is not due to a dramatic reduction in Rac activation, but
rather correlates with a marked decrease in the recruitment of activated Rac to the cell
membrane. This is particularly interesting given observations that forced localization of PAK to
the plasma membrane strongly activates PAK (15-17). One hypothesis to explain this activation is
that membrane localization of PAK is likely to increase the efficiency of its interaction with other
membrane-associated regulatory elements, such as activated Rac (18) and perhaps sphingolipids
(17,18). Taken together, these data strongly suggest that membrane localization is a crucial aspect
of PAK activation in vivo.
The recruitment of PAK to the cell membrane may be mediated by its direct interaction
with the adapter protein Nck (19-22). Nck is comprised of three tandem SH3 domains in its N-
terminus and a single, C-terminal SH2 domain (23). The SH3 domains mediate interaction with a
4
large number of binding partners (23), while the SH2 domain mediates binding to phosphotyrosine-
containing proteins such as activated receptor tyrosine kinases (RTKs; e.g. PDGFR, EGFR
(20,24,25)) and the Crk-associated substrate, p130CAS (26)). The interaction of Nck with PAK is
mediated through the second SH3 domain of Nck, which binds to a proline-rich region in the N-
terminus of PAK (19-21). In fibroblasts, this interaction occurs even in the absence of
extracellular stimuli (19-21). This suggests that in unstimulated cells, PAK and Nck exist in a
constitutive complex that can be rapidly relocated to membrane-associated, phosphotyrosine-rich
sites generated by growth factor stimulation or adhesion to ECM. The importance of this
interaction in PAK activation is underscored by the observation that expression of a membrane-
targeted Nck SH3 domain leads to constitutive PAK activation (15). Moreover, the observation
that a PAK mutant unable to bind Nck is severely impaired in its ability to promote cytoskeletal
organization (27) suggests a major role for this interaction in the physiological regulation of PAK
function.
Given the tight regulation of PAK activation by cell adhesion to ECM and the importance
of Nck binding in regulating PAK activity, I investigated whether adhesion might affect PAK-Nck
interaction. In the present work, I demonstrate that the ability of PAK to bind Nck is highly
dependent on cell adhesion and correlates with an anchorage-dependent change in PAK
phosphorylation. These data have significant implications for the regulation and localization of
PAK activity and are also believed to represent the first demonstration of an anchorage-




Antibodies     Polyclonal antibodies against the N- or C-terminus of PAK1 were from
Santa Cruz Biotechnology (used at 1:1000 for western blotting; 5µg per sample for IP). Antibodies
against Nck included a monoclonal from Transduction Laboratories (used at 1:1000 for blotting
and 2µg per sample for IP) and a polyclonal from Santa Cruz Biotechnology (used at 1:500 for
blotting and 5µg per sample for IP). Polyclonal antibody against the PDGFβ receptor was a
generous gift from K. DeMali and A. Kazlauskas and was used as described (28).
Phosphotyrosine was detected using monoclonal antibody 4G10 from Upstate Biotechnology.
Cell culture      NIH3T3 cells were maintained in DMEM containing 10% bovine calf
serum. Cells were placed in serum-free DMEM 12 to 18hrs prior to suspension culture or
harvesting. Suspension culture was performed as described (13). Briefly, cells were trypsinized,
collected by centrifugation, washed once with 2mg/ml soybean trypsin inhibitor in DMEM
containing 2% BSA, once with DMEM/BSA without inhibitor, then resuspended and rotated in the
same at 37OC for various times as indicated. Where indicated, cells were replated, after 1hr in
suspension, onto FN-coated tissue culture plates (13) for the indicated times. In some experiments,
DMEM containing 0.1% calf serum was used to starve cells and neutralize trypsin. These
conditions yielded identical results (data not shown).
Cell lysis, immunoprecipitation and western blotting     Cells were washed twice in
ice-cold PBS and then scraped or resuspended in Triton lysis buffer (50mM Tris pH 7.6, 150mM
NaCl, 1 mM each EDTA and EGTA, 1% Triton X100, supplemented with aprotinin, AEBSF,
pepstatin, sodium fluoride and sodium orthovanadate (Sigma)), using 1ml per 5x106 cells. Lysates
were transferred to microfuge tubes, which were then vortexed vigorously for 30sec, incubated on
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ice for 10min, and centrifuged at 4OC for 10min at approximately 15000x g. Pre-cleared lysates
were either frozen at –80OC or further clarified by incubation with protein G-sepharose beads
(Pharmingen) for 1h at 4OC, then used for immunoprecipitation. In some cases, a portion of the
lysates was removed prior to the addition of antibody and mixed with an equal volume of 2X
Laemmli sample buffer and boiled for 5min. The remaining lysates were incubated with antibodies
for 1-2 hrs at 4OC and then with protein-G-coupled sepharose beads (Pharmingen) for an
additional hour. In most cases, complexes were washed three times (1ml each) with lysis buffer.
For polyclonal Nck immunoprecipitations, complexes were washed once with lysis buffer then
three times with PBS containing 1% Tween20. Washed complexes were resuspended in 1X
Laemmli sample buffer and boiled for 5min. For routine SDS-PAGE analysis, samples were run
on standard BioRad mini-gels (10% for Nck western blots, 7.5% for PAK and PDGFR western
blots). Higher resolution gels contained 8% acrylamide, 0.5% bisacrylamide, and were cast in
large (15cm x 15cm) cassettes (Hoefer Scientific). Separated proteins were transferred to
nitrocellulose or PVDF membranes, which were then blocked and blotted using standard
techniques and antibodies as detailed above.
Phosphatase treatment     PAK immunoprecipitates were washed three times with lysis
buffer, twice with 0.05M Tris, pH 7.0, 0.1M NaCl, and once with buffer A (0.05M Tris-HCl, pH
7.9, 0.1M NaCl, 0.01M magnesium chloride). Immunoconjugates were resuspended in 50µl buffer
A alone or buffer A containing 0.5 units of calf intenstinal alkaline phosphatase (New England
Biolabs) and incubated at 30OC for 30min. Immunoconjugates were then washed twice in buffer
A and either resuspended in 1X Laemmli sample buffer and boiled for 5min or resuspended in
50µl 0.02M MES, pH 6.0, containing 0.75 units of potato acid phosphatase (Calbiochem) and
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incubated for 15 min at 30 °C. These latter samples were then washed in buffer A and boiled in
Laemmli sample buffer as described above.
Phosphopeptide analysis     Cells were serum-starved overnight then labeled for 4 h
with 1.0 mCi/ml 32P-orthophosphate in phosphate-free DMEM containing 2% BSA. For
suspension culture, the labeling medium was removed, the cells were rapidly washed, trypsinized,
collected, and resuspended in the original labeling medium, then incubated at 37OC with rotation
for 1 h. Cells were harvested and PAK was immunoprecipitated as described above. Radiolabeled
PAK was purified on SDS-PAGE gels and individual bands were excised and subjected to in-gel
trypsinization as described elsewhere (13). Phosphopeptides were analyzed by two-dimensional
separation on thin layer cellulose plates (13) or by HPLC (AP Biotechnology) on a reverse-phase
C18 column (Vydac) developed with a linear gradient of aqueous acetonitrile. For some
experiments, an excess of a synthetic peptide with the sequence NTSTMIGAGSK (single-letter
code), corresponding to the tryptic peptide containing serine 21 of PAK1, was added to the mix of
radioactive peptides before HPLC separation. Fractions were then analyzed by scintillation
counting and spectrophotometry at 215nm. The peptide was synthesized and purified by the
University of North Carolina Peptide Synthesis Facility.
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RESULTS AND DISCUSSION
Recruitment of PAK to activated RTK complexes requires cell adhesion.  Nck
can recruit PAK to activated RTKs (e.g. PDGFR) upon growth factor stimulation, which may
play a role in regulating PAK activity (20). Given the strong anchorage-dependence of PAK
activation by growth factors (12,13), the effect of cell adhesion on recruitment of PAK to
activated PDGFR was investigated (Fig 1). As previously reported (29), PDGF-stimulated
tyrosine phosphorylation of the PDGFR occurred efficiently in both adherent and non-adherent
NIH3T3 cells. Growth factor stimulation of adherent cells induced the formation of a complex
containing tyrosine-phosphorylated PDGFR, Nck, and PAK. In non-adherent cells, Nck was still
recruited to the activated PDGFR while PAK was completely absent from this complex. This
suggested that while the SH2-dependent recruitment of Nck to activated receptor is anchorage-
independent, the SH3-mediated interaction of Nck with PAK might be regulated by cell adhesion.
The interaction between PAK and Nck is anchorage-dependent.  To directly
investigate the effects of cell adhesion on PAK-Nck interaction, anti-Nck western blots were
performed on PAK immunoprecipitates from stably adherent NIH3T3 cells and cells that had
been incubated in suspension (Fig 2). Even in the absence of serum and growth factors, PAK
immunoprecipitates from stably adherent cells contained readily detectable levels of Nck,
consistent with previous reports (19,20). However, little or no Nck was detected in PAK
immunoprecipitates from non-adherent cells (Fig 2). The lack of PAK-Nck association was not
due to a decrease in the amount of Nck protein in non-adherent cells, as shown by Nck western
blots of adherent and non-adherent cell extracts (data not shown and Fig 4). Interestingly, the
interaction between Nck and PAK was also ablated by treatment of adherent cells with
cytochalasin D (Fig 2). It is important to point out that although the concentration of cytochalasin
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D used in these experiments allowed cells to remain loosely attached, it completely disrupted the
actin cytoskeleton and promoted cell rounding and complete tyrosine dephosphorylation of FAK
(data not shown). This indicates that, in NIH3T3 cells, the growth factor-independent interaction
between Nck and PAK requires a fully functional cellular interaction with the ECM.
PAK-Nck interaction is dynamically regulated by cell adhesion.  To further
investigate this anchorage-dependent interaction, the kinetics of PAK-Nck dissociation after
cellular detachment were determined (Fig 3). The amount of Nck co-precipitating with PAK
dropped dramatically (approximately 8-fold by densitometry) within 10min after detachment, and
was essentially undetectable at 30 and 60min. Interestingly, the loss of PAK-Nck interaction after
detachment was rapidly reversed by re-plating cells onto the ECM protein fibronectin (FN). The
amount of co-precipitating Nck in cells re-plated on FN for 15min was approximately 90% of the
level seen in stably adherent cells, while the level at 30min after re-plating was indistinguishable
from that of adherent cells (Fig 3).
Nck binding correlates with PAK phosphorylation. The rapid kinetics of PAK-Nck
dissociation and re-association suggest that the stability of the complex might be regulated by a
rapidly reversible post-translational modification, such as phosphorylation. Both PAK and Nck are
known phosphoproteins (1,23). However, the role of phosphorylation in regulating Nck function
has yet to be determined. Furthermore, while many of the details of PAK phosphorylation in vitro
have been elucidated, the complexity of its regulation in vivo is not completely understood, and its
regulation by cell adhesion has never been investigated.
Importantly, a recent report demonstrates that the association of Nck and PAK can be
regulated by phosphorylation (22). In this report, strong biochemical data indicated that
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phosphorylation of serine 21, a putative autophosphorylation site at the C-terminal end of the Nck-
binding region of PAK1, dramatically reduced the interaction between PAK and Nck (22).
Reduced Nck binding was also observed in cells in which PAK was robustly activated and
hyperphosphorylated either by mutation or expression of a constitutively active mutant of Cdc42
(22), suggesting a negative feedback loop in which PAK activation down-regulates interaction
with Nck.
Previous work has correlated PAK phosphorylation with an electrophoretic mobility shift
on SDS-PAGE gels – specifically, increasing phosphorylation of PAK correlates with slower
migration (22,30). This correlation was utilized to investigate whether the loss of Nck binding in
non-adherent cells coincided with a change in the phosphorylation state of PAK. Previous
experiments in the current report were performed using standard mini-gels and no shift in PAK
mobility was readily apparent. Therefore, to better visualize potential PAK mobility shifts,
subsequent experiments utilized larger, higher cross-linking gels (see EXPERIMENTAL
PROCEDURES). Using this method, PAK isolated from adherent, serum-starved cells runs as a
discrete doublet, while in non-adherent cells, only the faster migrating form is present (Fig 4a). A
slower migrating form of PAK reappears within an hour of re-plating cells on FN (Fig 4a). As
expected, this mobility shift is due to a difference in phosphorylation, as the slower migrating
species present in PAK immunoprecipitates from adherent cells are almost completely converted
to the faster migrating form by phosphatase treatment in vitro (Fig 4b). Significantly, this
differential phosphorylation correlates closely with the loss of Nck binding in non-adherent cells
(Fig 4a) and suggests that Nck binds exclusively to the more highly phosphorylated, slower
migrating form of PAK. This was confirmed in reciprocal co-immunoprecipitation experiments in
which the PAK present in Nck immunoprecipitates co-migrated exclusively with the slower
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migrating form of PAK that is present in adherent cells but completely absent from non-adherent
cells (Fig 4c).
The loss of PAK-Nck interaction in non-adherent cells and its correlation with PAK
dephosphorylation indicate that Nck binding is compromised under conditions in which PAK
activity is very low. This is somewhat surprising in light of the recent observations suggesting high
levels of PAK activity are responsible for disrupting PAK-Nck complexes (22). However, these
latter observations are in stark contrast to an earlier report in which a constitutively active double
point-mutant of PAK showed enhanced binding to Nck (27). The recovery of PAK-Nck
complexes from cells stimulated with growth factors and other agonists also supports the notion
that Nck remains associated with activated PAK under physiological conditions (15,16,19-
21,31,32). Therefore, there are some apparent contradictions regarding the role of PAK activity or
autophosphorylation in regulating Nck binding in vivo. However, there is still strong in vitro
evidence that indicates that PAK-Nck interaction can indeed be regulated by phosphorylation near
the proline-rich Nck-binding region (22). How might these observations be reconciled with the
current data?
One possible explanation is that serine 21 appears to be a relatively poor
autophosphorylation site (30), and may only be modified in this way when PAK is activated to
supraphysiological levels (e.g. by an excess of constitutively active Cdc42 or Rac). It is therefore
possible that phosphorylation of this site is indeed responsible for regulating Nck binding, but that
in vivo, this modification is catalyzed by a kinase other than PAK. Results thus far suggest that
such a kinase may be activated upon cellular detachment. To directly investigate the possibility
that cellular detachment might affect phosphorylation of this region, phosphopeptide mapping was
performed on radiolabeled PAK immunoprecipitated from 32P-labeled adherent cells and cells in
suspension. Separation of tryptic phosphopeptides by two-dimensional mapping or by HPLC
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revealed several adhesion-dependent changes in PAK phosphorylation (Fig 4d and data not
shown). To specifically identify changes in phosphorylation in and around serine 21, an excess of
purified, synthetic peptide corresponding to amino acids 19-29 of PAK1 (the tryptic fragment
containing serine 21) was added to the phosphopeptide mixtures to serve as a marker during
HPLC. While PAK from adherent cells contained several phosphopeptides not present in the non-
adherent sample (Fig 4d, fractions 20, 29, and 30), PAK from non-adherent cells contained a
phosphopeptide that co-eluted with the synthetic peptide (Fig 4d, fraction 26). These data suggest
that cellular detachment induces phosphorylation of PAK within a region known to regulate
interaction with Nck.
Regulation of PAK phosphorylation in vivo is complex and not fully understood. The shift
in electrophoretic mobility observed in Fig 4a suggests a net dephosphorylation of PAK in non-
adherent cells. However, Fig 4d demonstrates that under these conditions, PAK retains some
phosphates and even acquires new modifications (e.g. phosphorylation of the serine 21-containing
peptide) that are induced specifically, and perhaps uniquely, by the state of non-adherence.
Considerable effort has established that PAK is a substrate for both autophosphorylation (1,33) as
well as phosphorylation by other kinases (e.g. PDK1 (34), PKA (13)). Clearly, further analysis is
required to fully address the regulation of PAK phosphorylation by cell adhesion. Among the most
important issues to be addressed are what is the complete profile of PAK phosphorylation in
adherent versus non-adherent cells and how are the changes in phosphorylation mediated, i.e.
what kinases or phosphatases are involved and how are they regulated.
The importance of Nck-mediated PAK localization to the membrane is likely to be two-
fold. First, relocation to the membrane places PAK in close proximity with membrane-associated
activating factors, such as activated Rac (12) and sphingolipids (17), increasing the efficiency of
their interaction and, thereby, the efficiency of PAK activation (18). Second, membrane
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localization of PAK places it in an appropriate setting to exert its effects on lamellipodia extension
and cell motility, events that involve modulation of the actin cytoskeleton near the cell membrane
(35,36). Another intriguing possibility is that by recruiting PAK to sites of active growth factor
and/or cell adhesion signaling, the Nck-PAK interaction may be important in translating
extracellular gradients into intracellular asymmetry and, thus, establishing cell polarity (3). Given
the ability of PAK to regulate the actin cytoskeleton, cell motility, cytoplasmic signaling cascades,
and gene expression, the regulation of PAK-Nck interaction by cell adhesion provides an intriguing
new facet of regulation to this important signaling complex.
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FOOTNOTES
1. Abbreviations used are: AEBSF, 4-(2-aminoethyl)benzenesulfonyl fluoride; BSA, bovine serum
albumin; DMEM, Dulbecco’s modified Eagle’s medium; EGF, epidermal growth factor; EGFR,
EGF receptor; GTPase, guanosine triphosphatase; HPLC, high-performance liquid
chromatography; IP, immunoprecipitation; MES, 2-(N-morpholino)ethanesulfonic acid; PBS,
phosphate-buffered saline; PDGF, platelet-derived growth factor; PDGFR, PDGF receptor;
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FIGURE LEGENDS
Figure 1. Recruitment of PAK to activated PDGF receptor is anchorage-dependent.
PDGF receptor (PDGFR) was immunoprecipitated from adherent cells (Adh) or cells cultured in
suspension for 1h (Susp) before or after stimulation with 20ng/ml PDGF-BB for 5min as
indicated. Immunocomplexes were separated by SDS-PAGE and analyzed by western blotting
with antibodies against the PDGFR (to confirm equal loading), Nck and PAK. For analysis of
PDGFR tyrosine phosphorylation, anti-PDGFR blots were stripped and re-probed with anti-
phospotyrosine (P-Tyr) antibody.
Figure 2. Cell adhesion regulates PAK-Nck interaction.  PAK was immunoprecipitated from
serum-starved, stably adherent cells (Adh), cells cultured in suspension (Susp), or adherent cells
treated with 2.5µM cytochalasin D for 30min (CD). Immunocomplexes were separated by SDS-
PAGE and analyzed by western blotting with antibodies against PAK and Nck. Ten µg of whole
cell extract (wce) from stably adherent cells was run alongside the immunoprecipitates to more
easily distinguish bands of interest (indicated by arrowheads) from background immunoglobulin
bands.
Figure 3. PAK-Nck interaction is reversibly and dynamically regulated by cell adhesion.
PAK was immunoprecipitated from serum-starved, stably adherent cells (Adh), and cells cultured
in suspension (Susp) or re-plated onto FN-coated plates (FN) for the indicated periods of time (in
minutes). Immunocomplexes were separated by SDS-PAGE and analyzed by western blotting
with antibodies against PAK and Nck. Ten µg of whole cell extract (wce) from stably adherent
cells was run alongside the immunoprecipitates to more easily distinguish bands of interest
(indicated by arrowheads) from background immunoglobulin bands.
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Figure 4. Loss of PAK-Nck interaction correlates with dephosphorylation of PAK. A,
PAK was immunoprecipitated from serum-starved, stably adherent cells (Adh), cells cultured in
suspension (Susp), or cells re-plated onto FN-coated plates for 1h (FN). Immunocomplexes were
separated in large, high cross-linker SDS-PAGE gels and analyzed by western blotting with
antibodies against PAK and Nck. Whole cell extracts from non-adherent or re-plated cells were
run along side the immunoprecipitates to distinguish bands of interest (indicated by arrowheads)
and to confirm equal amounts of PAK and Nck in these culture conditions. B, PAK was
immunoprecipitated from adherent cells (Adh) or cells in suspension (Susp) and incubated in
phosphatase buffer alone or buffer containing potato acid phosphatase (PAP) and/or calf
intenstinal phosphatase (CIP) as indicated. Proteins were resolved on high cross-linker SDS-
PAGE gels and analyzed by western blotting with antibodies against PAK. C, Nck was
quantitatively immunoprecipitated from stably adherent cells, and the supernatant extract (Super)
from this immunoprecipitation was immediately re-immunoprecipitated with antibodies against
PAK. These immunocomplexes were run on high cross-linker gels alongside PAK
immunoprecipitates from stably adherent cells (Adh) or cells in suspension (Susp) and analyzed by
anti-PAK western blotting. The position of a 64000 Da molecular weight marker (64) is indicated.
D, 32P-labeled tryptic peptides of PAK isolated from adherent cells (white bars) or cells in
suspension for 1h (shaded bars) were doped with an excess of an unlabeled, synthetic peptide
comprising amino acids 19-29 of PAK1 (see Experimental Procedures) and separated by
HPLC. Portions of the indicated fractions were analyzed by liquid scintillation counting (bars) to
determine phosphate content (in CPM) or by spectrophotometry at 215 nm (dashed line; A215)
to assess the presence of the synthetic peptide.




